Showing 781-790 of 10220 results for "".
Science of Skincare Summit 2024:Presentation of Disease in Patients with Skin of Color
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-presentation-of-disease-in-patients-with-skin-of-color/29456/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Nada Elbuluk, MD, a dermatologist at the University of Southern California specializing in pigmentary disorders and skin of color, about some of the challenges of diagnosing disease such as erythema in patients with skin of colorScience of Skincare Summit 2024:What's Going On With Medical Dermatology?
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-whats-going-on-with-medical-dermatology/29451/Todd Schlesinger, MD, James Del Rosso, DO, and Neal Bhatia, MD, discuss challenges facing medical dermatology, and what can be done to save it, as well as the importance of encouraging young dermatologists to become involved with clinical research. This discussion was recorded at the Science of SkinDr. Hartman Discusses the Importance of Skin of Color Update
https://practicaldermatology.com/topics/skin-of-color/dr-hartman-discusses-the-importance-of-skin-of-color-update/28656/Corey L. Hartman, MD, FAAD, Founder of Skin Wellness Dermatology and YoungMD Connect Advisor, shares insights and key takeaways he looks forward to at the Skin of Color Update.Skin-vincible: A Children's Book for Living with Ichthyosis
https://practicaldermatology.com/topics/rare-disease/skin-vincible-a-childrens-book-for-living-with-ichthyosis/20260/Drs. Andrea Rustad, a graduate of the Northwestern University Feinberg School of Medicine and incoming dermatology resident at the University of Wisconsin, and Amy Paller, chair of the department of dermatology at the Northwestern Feinberg School of Medicine in Chicago, talk with Practical DermatoloFactor in Patient Satisfaction Matrix for Best Results
https://practicaldermatology.com/conferences/maui-derm-2024/factor-in-patient-satisfaction-matrix-for-best-results/20249/Chief Medical Editor Neil Bhatia, MD speaks with Maui Derm presenter and educator William P. Werschler, MD about cosmetic updates, including his “patient satisfaction matrix” that helps doctors and patients align on expectations of the outcomes of procedures.Is Your Sunscreen Safe?
https://practicaldermatology.com/conferences/scale-2023/is-your-sunscreen-safe/20187/Practical Dermatology magazine's newest editorial advisory board member Christopher Bunick, MD, PhD, shares advice on how to choose benzene-free sunscreens and offers tips on making smarter choices about sun protection.Skin Checks and Patient Education on Actinic Keratoses
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-checks-and-patient-education-on-actinic-keratoses/20132/During skin checks, it's important for dermatologists to educate patients, especially younger ones, about the extent of sun damage and the benefits of field treatments. Anthony Rossi, MD and Vishal Patel, MD discuss their approaches.Six simple tips for an excellent dermatology website design
https://practicaldermatology.com/topics/practice-management/six-simple-tips-for-an-excellent-dermatology-website-design/20068/Is your website design outdated? Are you dreading the redesign? If so, check out this short video from Ekwa Marketing (www.ekwa.com) for tips on making the most of your redesign.Acne Treatment Strategies
https://practicaldermatology.com/conferences/maui-derm-2022/acne-treatment-strategies/20046/Guy F. Webster, MD, PhD shares acne management strategies that are effective for patients and help minimize use of antibiotics. He also discusses the continued role for isotretinoin for the right candidates.DermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologies with Avit